Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trial. (Q39320917)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

phase I clinical trial

0 references

phase II clinical trial

0 references

Fiona Thistlethwaite

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Ryan D Guest

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Natalia Kirillova

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Sam Mowbray

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Hannah Gornall

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Dominic G Rothwell

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Eleanor J Cheadle

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Eric Austin

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Keith Smith

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Suzanne M Watt

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Klaus Kühlcke

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Nigel Westwood

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Robert E Hawkins

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

5 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

63

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

133-145

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24190544%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

https://scigraph.springernature.com/pub.10.1007/s00262-013-1492-9

0 references

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Targeted immunotherapy of cancer with CAR T cells: achievements and challenges.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

A single chain Fv derived from a filamentous phage library has distinct tumor targeting advantages over one derived from a hybridoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Primary polyclonal human T lymphocytes targeted to carcino-embryonic antigens and neural cell adhesion molecule tumor antigens by CD3zeta-based chimeric immune receptors.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

T lymphocytes isolated from patients with advanced colorectal cancer are suitable for gene immunotherapy approaches.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Clinical evaluation of TRICOM vector therapeutic cancer vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Preclinical evaluation of an automated closed fluid management device: CytomateTM, for washing out DMSO from hematopoietic stem cell grafts after thawing

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

A novel 'sort-suicide' fusion gene vector for T cell manipulation

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Retronectin-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydras

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Paths to stemness: building the ultimate antitumour T cell.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE® bioreactor

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex).

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1492-9

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39320917&oldid=1749493094"